Global Biosimilar Drug Market Insights and Forecast to 2031

Report ID: 1196645 | Published Date: Feb 2026 | No. of Page: 97 | Base Year: 2025 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Study Coverage
    1.1 Biosimilar Drug Product Introduction
    1.2 Market by Type
        1.2.1 Global Biosimilar Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Injection
        1.2.3 Tablets
        1.2.4 Other Types
    1.3 Market by Application
        1.3.1 Global Biosimilar Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Ankylosing Spondylitis
        1.3.3 Tumor
        1.3.4 Rheumatoid Arthrtis
        1.3.5 Cardiovascular
        1.3.6 Other Application
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Biosimilar Drug Sales Estimates and Forecasts 2017-2028
    2.2 Global Biosimilar Drug Revenue Estimates and Forecasts 2017-2028
    2.3 Global Biosimilar Drug Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Biosimilar Drug Sales by Region
        2.4.1 Global Biosimilar Drug Sales by Region (2017-2022)
        2.4.2 Global Sales Biosimilar Drug by Region (2023-2028)
    2.5 Global Biosimilar Drug Revenue by Region
        2.5.1 Global Biosimilar Drug Revenue by Region (2017-2022)
        2.5.2 Global Biosimilar Drug Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Biosimilar Drug Sales by Manufacturers
        3.1.1 Global Top Biosimilar Drug Manufacturers by Sales (2017-2022)
        3.1.2 Global Biosimilar Drug Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosimilar Drug in 2021
    3.2 Global Biosimilar Drug Revenue by Manufacturers
        3.2.1 Global Biosimilar Drug Revenue by Manufacturers (2017-2022)
        3.2.2 Global Biosimilar Drug Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Biosimilar Drug Revenue in 2021
    3.3 Global Biosimilar Drug Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Biosimilar Drug Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Biosimilar Drug Sales by Type
        4.1.1 Global Biosimilar Drug Historical Sales by Type (2017-2022)
        4.1.2 Global Biosimilar Drug Forecasted Sales by Type (2023-2028)
        4.1.3 Global Biosimilar Drug Sales Market Share by Type (2017-2028)
    4.2 Global Biosimilar Drug Revenue by Type
        4.2.1 Global Biosimilar Drug Historical Revenue by Type (2017-2022)
        4.2.2 Global Biosimilar Drug Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Biosimilar Drug Revenue Market Share by Type (2017-2028)
    4.3 Global Biosimilar Drug Price by Type
        4.3.1 Global Biosimilar Drug Price by Type (2017-2022)
        4.3.2 Global Biosimilar Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Biosimilar Drug Sales by Application
        5.1.1 Global Biosimilar Drug Historical Sales by Application (2017-2022)
        5.1.2 Global Biosimilar Drug Forecasted Sales by Application (2023-2028)
        5.1.3 Global Biosimilar Drug Sales Market Share by Application (2017-2028)
    5.2 Global Biosimilar Drug Revenue by Application
        5.2.1 Global Biosimilar Drug Historical Revenue by Application (2017-2022)
        5.2.2 Global Biosimilar Drug Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Biosimilar Drug Revenue Market Share by Application (2017-2028)
    5.3 Global Biosimilar Drug Price by Application
        5.3.1 Global Biosimilar Drug Price by Application (2017-2022)
        5.3.2 Global Biosimilar Drug Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Biosimilar Drug Market Size by Type
        6.1.1 North America Biosimilar Drug Sales by Type (2017-2028)
        6.1.2 North America Biosimilar Drug Revenue by Type (2017-2028)
    6.2 North America Biosimilar Drug Market Size by Application
        6.2.1 North America Biosimilar Drug Sales by Application (2017-2028)
        6.2.2 North America Biosimilar Drug Revenue by Application (2017-2028)
    6.3 North America Biosimilar Drug Market Size by Country
        6.3.1 North America Biosimilar Drug Sales by Country (2017-2028)
        6.3.2 North America Biosimilar Drug Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Biosimilar Drug Market Size by Type
        7.1.1 Europe Biosimilar Drug Sales by Type (2017-2028)
        7.1.2 Europe Biosimilar Drug Revenue by Type (2017-2028)
    7.2 Europe Biosimilar Drug Market Size by Application
        7.2.1 Europe Biosimilar Drug Sales by Application (2017-2028)
        7.2.2 Europe Biosimilar Drug Revenue by Application (2017-2028)
    7.3 Europe Biosimilar Drug Market Size by Country
        7.3.1 Europe Biosimilar Drug Sales by Country (2017-2028)
        7.3.2 Europe Biosimilar Drug Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Biosimilar Drug Market Size by Type
        8.1.1 Asia Pacific Biosimilar Drug Sales by Type (2017-2028)
        8.1.2 Asia Pacific Biosimilar Drug Revenue by Type (2017-2028)
    8.2 Asia Pacific Biosimilar Drug Market Size by Application
        8.2.1 Asia Pacific Biosimilar Drug Sales by Application (2017-2028)
        8.2.2 Asia Pacific Biosimilar Drug Revenue by Application (2017-2028)
    8.3 Asia Pacific Biosimilar Drug Market Size by Region
        8.3.1 Asia Pacific Biosimilar Drug Sales by Region (2017-2028)
        8.3.2 Asia Pacific Biosimilar Drug Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Biosimilar Drug Market Size by Type
        9.1.1 Latin America Biosimilar Drug Sales by Type (2017-2028)
        9.1.2 Latin America Biosimilar Drug Revenue by Type (2017-2028)
    9.2 Latin America Biosimilar Drug Market Size by Application
        9.2.1 Latin America Biosimilar Drug Sales by Application (2017-2028)
        9.2.2 Latin America Biosimilar Drug Revenue by Application (2017-2028)
    9.3 Latin America Biosimilar Drug Market Size by Country
        9.3.1 Latin America Biosimilar Drug Sales by Country (2017-2028)
        9.3.2 Latin America Biosimilar Drug Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Biosimilar Drug Market Size by Type
        10.1.1 Middle East and Africa Biosimilar Drug Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Biosimilar Drug Revenue by Type (2017-2028)
    10.2 Middle East and Africa Biosimilar Drug Market Size by Application
        10.2.1 Middle East and Africa Biosimilar Drug Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Biosimilar Drug Revenue by Application (2017-2028)
    10.3 Middle East and Africa Biosimilar Drug Market Size by Country
        10.3.1 Middle East and Africa Biosimilar Drug Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Biosimilar Drug Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 CP Guojian Pharma
        11.1.1 CP Guojian Pharma Corporation Information
        11.1.2 CP Guojian Pharma Overview
        11.1.3 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 CP Guojian Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 CP Guojian Pharma Recent Developments
    11.2 Biotech Pharma
        11.2.1 Biotech Pharma Corporation Information
        11.2.2 Biotech Pharma Overview
        11.2.3 Biotech Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Biotech Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Biotech Pharma Recent Developments
    11.3 Celgen Pharma
        11.3.1 Celgen Pharma Corporation Information
        11.3.2 Celgen Pharma Overview
        11.3.3 Celgen Pharma Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Celgen Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Celgen Pharma Recent Developments
    11.4 Henlius
        11.4.1 Henlius Corporation Information
        11.4.2 Henlius Overview
        11.4.3 Henlius Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Henlius Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Henlius Recent Developments
    11.5 Amgen
        11.5.1 Amgen Corporation Information
        11.5.2 Amgen Overview
        11.5.3 Amgen Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Amgen Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Amgen Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Corporation Information
        11.6.2 Eli Lilly Overview
        11.6.3 Eli Lilly Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Eli Lilly Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Eli Lilly Recent Developments
    11.7 Sandoz
        11.7.1 Sandoz Corporation Information
        11.7.2 Sandoz Overview
        11.7.3 Sandoz Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Sandoz Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Sandoz Recent Developments
    11.8 Changchun High Tech
        11.8.1 Changchun High Tech Corporation Information
        11.8.2 Changchun High Tech Overview
        11.8.3 Changchun High Tech Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Changchun High Tech Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Changchun High Tech Recent Developments
    11.9 Innovent
        11.9.1 Innovent Corporation Information
        11.9.2 Innovent Overview
        11.9.3 Innovent Biosimilar Drug Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Innovent Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Innovent Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Biosimilar Drug Industry Chain Analysis
    12.2 Biosimilar Drug Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Biosimilar Drug Production Mode & Process
    12.4 Biosimilar Drug Sales and Marketing
        12.4.1 Biosimilar Drug Sales Channels
        12.4.2 Biosimilar Drug Distributors
    12.5 Biosimilar Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Biosimilar Drug Industry Trends
    13.2 Biosimilar Drug Market Drivers
    13.3 Biosimilar Drug Market Challenges
    13.4 Biosimilar Drug Market Restraints
14 Key Findings in The Global Biosimilar Drug Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Biosimilar Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Injection
    Table 3. Major Manufacturers of Tablets
    Table 4. Major Manufacturers of Other Types
    Table 5. Global Biosimilar Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Biosimilar Drug Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Biosimilar Drug Sales by Region (2017-2022) & (K Dose)
    Table 8. Global Biosimilar Drug Sales Market Share by Region (2017-2022)
    Table 9. Global Biosimilar Drug Sales by Region (2023-2028) & (K Dose)
    Table 10. Global Biosimilar Drug Sales Market Share by Region (2023-2028)
    Table 11. Global Biosimilar Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Biosimilar Drug Revenue Market Share by Region (2017-2022)
    Table 13. Global Biosimilar Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Biosimilar Drug Revenue Market Share by Region (2023-2028)
    Table 15. Global Biosimilar Drug Sales by Manufacturers (2017-2022) & (K Dose)
    Table 16. Global Biosimilar Drug Sales Share by Manufacturers (2017-2022)
    Table 17. Global Biosimilar Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Biosimilar Drug Revenue Share by Manufacturers (2017-2022)
    Table 19. Biosimilar Drug Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 20. Global Biosimilar Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Biosimilar Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar Drug as of 2021)
    Table 22. Biosimilar Drug Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Biosimilar Drug Product Offered
    Table 24. Date of Manufacturers Enter into Biosimilar Drug Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
    Table 27. Global Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
    Table 28. Global Biosimilar Drug Sales Share by Type (2017-2022)
    Table 29. Global Biosimilar Drug Sales Share by Type (2023-2028)
    Table 30. Global Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Biosimilar Drug Revenue Share by Type (2017-2022)
    Table 33. Global Biosimilar Drug Revenue Share by Type (2023-2028)
    Table 34. Biosimilar Drug Price by Type (2017-2022) & (USD/Dose)
    Table 35. Global Biosimilar Drug Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 36. Global Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
    Table 37. Global Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
    Table 38. Global Biosimilar Drug Sales Share by Application (2017-2022)
    Table 39. Global Biosimilar Drug Sales Share by Application (2023-2028)
    Table 40. Global Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Biosimilar Drug Revenue Share by Application (2017-2022)
    Table 43. Global Biosimilar Drug Revenue Share by Application (2023-2028)
    Table 44. Biosimilar Drug Price by Application (2017-2022) & (USD/Dose)
    Table 45. Global Biosimilar Drug Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 46. North America Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
    Table 47. North America Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
    Table 48. North America Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
    Table 51. North America Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
    Table 52. North America Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
    Table 55. North America Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
    Table 56. North America Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
    Table 59. Europe Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
    Table 60. Europe Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
    Table 63. Europe Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
    Table 64. Europe Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
    Table 67. Europe Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
    Table 68. Europe Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
    Table 71. Asia Pacific Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
    Table 72. Asia Pacific Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
    Table 75. Asia Pacific Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
    Table 76. Asia Pacific Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Biosimilar Drug Sales by Region (2017-2022) & (K Dose)
    Table 79. Asia Pacific Biosimilar Drug Sales by Region (2023-2028) & (K Dose)
    Table 80. Asia Pacific Biosimilar Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Biosimilar Drug Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
    Table 83. Latin America Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
    Table 84. Latin America Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
    Table 87. Latin America Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
    Table 88. Latin America Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
    Table 91. Latin America Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
    Table 92. Latin America Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Biosimilar Drug Sales by Type (2017-2022) & (K Dose)
    Table 95. Middle East and Africa Biosimilar Drug Sales by Type (2023-2028) & (K Dose)
    Table 96. Middle East and Africa Biosimilar Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Biosimilar Drug Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Biosimilar Drug Sales by Application (2017-2022) & (K Dose)
    Table 99. Middle East and Africa Biosimilar Drug Sales by Application (2023-2028) & (K Dose)
    Table 100. Middle East and Africa Biosimilar Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Biosimilar Drug Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Biosimilar Drug Sales by Country (2017-2022) & (K Dose)
    Table 103. Middle East and Africa Biosimilar Drug Sales by Country (2023-2028) & (K Dose)
    Table 104. Middle East and Africa Biosimilar Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Biosimilar Drug Revenue by Country (2023-2028) & (US$ Million)
    Table 106. CP Guojian Pharma Corporation Information
    Table 107. CP Guojian Pharma Description and Major Businesses
    Table 108. CP Guojian Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 109. CP Guojian Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. CP Guojian Pharma Recent Developments
    Table 111. Biotech Pharma Corporation Information
    Table 112. Biotech Pharma Description and Major Businesses
    Table 113. Biotech Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 114. Biotech Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Biotech Pharma Recent Developments
    Table 116. Celgen Pharma Corporation Information
    Table 117. Celgen Pharma Description and Major Businesses
    Table 118. Celgen Pharma Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 119. Celgen Pharma Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Celgen Pharma Recent Developments
    Table 121. Henlius Corporation Information
    Table 122. Henlius Description and Major Businesses
    Table 123. Henlius Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 124. Henlius Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Henlius Recent Developments
    Table 126. Amgen Corporation Information
    Table 127. Amgen Description and Major Businesses
    Table 128. Amgen Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 129. Amgen Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Amgen Recent Developments
    Table 131. Eli Lilly Corporation Information
    Table 132. Eli Lilly Description and Major Businesses
    Table 133. Eli Lilly Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 134. Eli Lilly Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Eli Lilly Recent Developments
    Table 136. Sandoz Corporation Information
    Table 137. Sandoz Description and Major Businesses
    Table 138. Sandoz Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 139. Sandoz Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Sandoz Recent Developments
    Table 141. Changchun High Tech Corporation Information
    Table 142. Changchun High Tech Description and Major Businesses
    Table 143. Changchun High Tech Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 144. Changchun High Tech Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Changchun High Tech Recent Developments
    Table 146. Innovent Corporation Information
    Table 147. Innovent Description and Major Businesses
    Table 148. Innovent Biosimilar Drug Sales (K Dose), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 149. Innovent Biosimilar Drug Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Innovent Recent Developments
    Table 151. Key Raw Materials Lists
    Table 152. Raw Materials Key Suppliers Lists
    Table 153. Biosimilar Drug Distributors List
    Table 154. Biosimilar Drug Customers List
    Table 155. Biosimilar Drug Market Trends
    Table 156. Biosimilar Drug Market Drivers
    Table 157. Biosimilar Drug Market Challenges
    Table 158. Biosimilar Drug Market Restraints
    Table 159. Research Programs/Design for This Report
    Table 160. Key Data Information from Secondary Sources
    Table 161. Key Data Information from Primary Sources
List of Figures
    Figure 1. Biosimilar Drug Product Picture
    Figure 3. Global Biosimilar Drug Market Share by Type in 2021 & 2028
    Figure 3. Injection Product Picture
    Figure 4. Tablets Product Picture
    Figure 5. Other Types Product Picture
    Figure 6. Global Biosimilar Drug Market Share by Application in 2021 & 2028
    Figure 7. Ankylosing Spondylitis
    Figure 8. Tumor
    Figure 9. Rheumatoid Arthrtis
    Figure 10. Cardiovascular
    Figure 11. Other Application
    Figure 12. Biosimilar Drug Report Years Considered
    Figure 13. Global Biosimilar Drug Sales 2017-2028 (K Dose)
    Figure 14. Global Biosimilar Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Biosimilar Drug Revenue 2017-2028 (US$ Million)
    Figure 16. Global Biosimilar Drug Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Biosimilar Drug Sales Market Share by Region (2017-2022)
    Figure 18. Global Biosimilar Drug Sales Market Share by Region (2023-2028)
    Figure 19. North America Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
    Figure 20. North America Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
    Figure 22. Europe Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
    Figure 24. Asia-Pacific Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
    Figure 26. Latin America Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Biosimilar Drug Sales YoY (2017-2028) & (K Dose)
    Figure 28. Middle East & Africa Biosimilar Drug Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Biosimilar Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Biosimilar Drug in the World: Market Share by Biosimilar Drug Revenue in 2021
    Figure 31. Global Biosimilar Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Biosimilar Drug Sales Market Share by Type (2017-2028)
    Figure 33. Global Biosimilar Drug Revenue Market Share by Type (2017-2028)
    Figure 34. Global Biosimilar Drug Sales Market Share by Application (2017-2028)
    Figure 35. Global Biosimilar Drug Revenue Market Share by Application (2017-2028)
    Figure 36. North America Biosimilar Drug Sales Market Share by Type (2017-2028)
    Figure 37. North America Biosimilar Drug Revenue Market Share by Type (2017-2028)
    Figure 38. North America Biosimilar Drug Sales Market Share by Application (2017-2028)
    Figure 39. North America Biosimilar Drug Revenue Market Share by Application (2017-2028)
    Figure 40. North America Biosimilar Drug Sales Share by Country (2017-2028)
    Figure 41. North America Biosimilar Drug Revenue Share by Country (2017-2028)
    Figure 42. U.S. Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Biosimilar Drug Sales Market Share by Type (2017-2028)
    Figure 45. Europe Biosimilar Drug Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Biosimilar Drug Sales Market Share by Application (2017-2028)
    Figure 47. Europe Biosimilar Drug Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Biosimilar Drug Sales Share by Country (2017-2028)
    Figure 49. Europe Biosimilar Drug Revenue Share by Country (2017-2028)
    Figure 50. Germany Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 51. France Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Biosimilar Drug Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Biosimilar Drug Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Biosimilar Drug Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Biosimilar Drug Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Biosimilar Drug Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Biosimilar Drug Revenue Share by Region (2017-2028)
    Figure 61. China Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 64. India Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 66. China Taiwan Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Biosimilar Drug Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Biosimilar Drug Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Biosimilar Drug Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Biosimilar Drug Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Biosimilar Drug Sales Share by Country (2017-2028)
    Figure 75. Latin America Biosimilar Drug Revenue Share by Country (2017-2028)
    Figure 76. Mexico Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Biosimilar Drug Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Biosimilar Drug Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Biosimilar Drug Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Biosimilar Drug Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Biosimilar Drug Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Biosimilar Drug Revenue Share by Country (2017-2028)
    Figure 85. Turkey Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 87. UAE Biosimilar Drug Revenue (2017-2028) & (US$ Million)
    Figure 88. Biosimilar Drug Value Chain
    Figure 89. Biosimilar Drug Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius
Amgen
Eli Lilly
Sandoz
Changchun High Tech
Innovent
Frequently Asked Questions
Biosimilar Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biosimilar Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biosimilar Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Candle

Candle market is segmented Raw Materials and by Application. Players, stakeholders, and other par ... Read More

Car Navigation

Car Navigation market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More